ArmstrongCPBlowerAL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut1987; 28: 527–32.
2.
GriffenMRRayWASchaffnerW. Non-steroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med1988; 109: 359–63.
3.
GuessHAWestRStrandLM, Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983. J Clin Epidemiol1988; 41: 35–15.
4.
CarsonJLStromBLSoperKA, The association of nonsteroidal anti-inflammatory drugs with upper gastrointestinal tract bleeding. Arch Intern Med1987; 147: 85–8.
5.
HershelJFeldAPereraDR. Certain nonsteroidal antiinflammatory drugs and hospitalization for upper gastrointestinal bleeding. Pharmacotherapy1985; 5: 280–4.
6.
BeardKWalkerAMPereraDR, Nonsteroidal antiinflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly. Arch Intern Med1987; 147: 1621–3.
7.
SollAH. Pathogenesis of peptic ulcer disease and implications for therapy. N Engl J Med1990; 322: 909–16.
CarsonJLStromBLMorseML, The relative gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. Arch Intern Med1987; 147: 1054–9.
10.
EhsanullahRSBPageMCTildesleyG, Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: Controlled trial of ranitidine. Br Med J1988; 297: 1017–21.
SilenW. Gastric mucosal defense and repair. In: JohnsonLR, ed. Physiology of the gastrointestinal tract. 2nd ed.New York: Raven Press, 1987: 1055–69.
16.
AllenAGamerA. A progress report: Mucus and bicarbonate secretion in the stomach and their possible role in mucosal protection. Gut1980; 21: 249–62.
17.
RobertANezamisJELancasterC, Cytoprotection by prostaglandins in rats: Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology1979; 77: 433–43.
18.
KauffmanGLWhittleBJRAuresD, Effects of prostacyclin and a stable analogue, 6β-PGl on gastric secretion, mucosal blood flow and blood pressure in conscious dogs. Gastroenterology1979; 77: 1301–6.
19.
JohannsonCKollbergB. Stimulation by intragastrically administered E2 prostaglandins of human gastric mucus output. Eur J Clin Invest1979; 9: 229–32.
20.
ReesWDWTurnbergLA. Mechanisms of gastric mucosal protection: A role for the “mucus-bicarbonate” barrier. Clin Sci1982; 62: 343–8.
21.
TarnawskiAHollanderDKrauseWJ, Does sucralfate affect the normal gastric mucosa?Gastroenterology1986; 90: 893–905.
22.
ColemanJCLaczJPBrowneRK, Effects of sucralfate or mild irritants on gastric mucosal damage and prostaglandin E2 production. S Afr Med J1988; 74 (suppl): 19–22.
23.
KonturekSJKwiecienNObtulowiczW, Double-blind controlled study on the effect of sucralfate on gastric prostaglandin formation and micro-bleeding in normal and aspirin treated man. Gut1986; 27: 1450–6.
24.
ShepherdHAChirBFineD, Effect of sucralfate and cimetidine on rheumatoid patients with active gastroduodenal lesions who are taking non-steroidal anti-inflammatory drugs. Am J Med1989; 86 (suppl 6A): 49–54.
25.
ShorrockCJReesWDW. Effect of sucralfate on human gastric bicarbonate secretion and local prostaglandin E2 metabolism. Am J Med1989; 86 (suppl 6A): 2–4.
26.
SternALWardFHartleyG. Protective effect of sucralfate against aspirin induced damage to human gastric mucosa. Am J Med1987; 83 (suppl 3B): 83–5.
27.
MorrisGPKeenanCMMacnaughtonWK, Protection of rat gastric mucosa by sucralfate: Effects of luminal stasis and of inhibition of prostaglandin synthesis. Am J Med1989; 86 (suppl 6A): 10–6.
28.
Shea-DonohueTSteelLMontcalmE, Gastric protection by sucralfate: Role of mucus and prostaglandins. Gastroenterology1986; 92: 660–6.
29.
QuadrosERamsamoojEWilsonDE. Role of mucus and prostaglandins in the gastric mucosal protective actions of sucralfate against ethanol-induced injury in the rat. Am J Med1987; 83 (suppl 3B): 19–23.
30.
Tasman-JonesCMorrisonG. Sucralfate interactions with gastric mucus. Am J Med1989; 86 (suppl 6A): 5–9.
31.
TarnawskiAHollanderDStachuraJ, Trophic effect of long-term sucralfate treatment on the gastric mucosa: A key to prophylactic efficacy? (abstract)Gastroenterology1985; 88: 1610.
32.
SzaboSBrownA. Prevention of ethanol-induced vascular injury and gastric mucosal lesions by sucralfate and its components: Possible role of endogenous sulfhydryls. Proc Soc Exp Biol Med1987; 285: 493–7.
33.
TeslerMALimES. Protection of gastric mucosa by sucralfate from aspirin-induced erosions. J Clin Gastroenterol1981; 3 (suppl 2): 175–9.
34.
McCarthyDM. Nonsteroidal antiinflammatory drug-induced ulcers: Management by traditional therapies. Gastroenterology1989; 96: 662–74.
35.
SternALWardFSievertW. Lack of gastric mucosal protection by sucralfate during long-term aspirin ingestion in humans. Am J Med1989; 86 (suppl 6A): 66–9.
36.
WuWCCastellDO. Does sucralfate protect against aspirin-induced mucosal lesions? Yes and no! (abstract)Gastroenterology1984; 87: 1303.
37.
LanzaFPeaceKGustitusL, A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration. Am J Gastroenterol1988; 83: 143–6.